DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Sledge GW, Nauberg D, Bernardo P. et al.
Phase III trial of doxorubicin, paclitaxel and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
J Clin Oncol 2003; 21: 588-592
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.